Note: Ingredients listed on restricted chemical lists
EC/CAS
128-37-0
Name of the chemical
2,6-di-tert-butyl-p-cresol
Concentration
>=0.1-<1%
EC/CAS
302-79-4
Name of the chemical
Tretinoin (INN) (retinoic acid and its salts)
Concentration
>=0.1-<1%
General Information
Version
1.0
Revision date
2014-02-17
Product name
RETIN-A Cream
Product name
RETIN-A Cream
Identification on the label/Trade name
For health and safety information during
Substance name
tretinoin
1.2.1 Relevant identified uses
Finished Pharmaceutical Product, Pharmacotherapeutic group: Anti-acne preparations, This SDS is only intended for occupational use and not for consumer use (see patient packaging insert for consumer use).This SDS is written to provide environmental, health and safety information for personnel that will be handling this finished pharmaceutical
supplier name
Janssen Ortho LLC
Emergency telephone
+18097878541800, +32 14 60 24 44
Icons in SDS
Company Information
company name
Janssen Ortho LLC
e-mail address of the competent person responsible for the Safety Data Sheet
SDSJanssen@its.jnj.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H360
Hazard statements
Code
Statements
H360
May damage fertility or the unborn child
Section 2
SECTION 2: Hazards identification
OSHA Emergency Overview Form cream Colour light yellow Odour no data available Hazard Summary This Finished Pharmaceutical Product is non-hazardous based on chemical classification rules. Refer to the pharmacotherapeutic group (section 1.2) and the patient packaging insert to evaluate the possible workplace hazards when this Finished Pharmaceutical Product is accidently leaking, broken or crushed. GHS Classification Reproductive toxicity Category 1B GHS Label element Hazard pictograms
Signal word
Danger Hazard statements H360 May damage fertility or the unborn child Precautionary statements Prevention P201 Obtain special instructions before use P202 Do not handle until all safety precautions have been read and understood P280 Wear protective gloves/ protective clothing Response P308 + P313 IF exposed or concerned: Get medical advice/ attention Storage P405 Store locked up Disposal P501 Dispose of contents/ container to an approved waste disposal plant Medicinal products in the finished state, intended for the final user, are not subject to GHS labeling. Self-Ignitable no data available
Medical Conditions Generally Aggravated by Exposure
None known. Symptoms of Overexposure Repeated or prolonged skin contact may cause allergic reactions with susceptible persons. Consult the patient packaging insert for more information about this Finished Pharmaceutical Product. Carcinogenicity
2.1 Classification of the substance or mixture
Reproductive toxicity : Category 1B
